Berlin Heart's Excor heart pump helps children with heart failure survive longer while awaiting a heart transplant, but risks of infection and other serious side effects remain high, according to a new study.
Children with heart failure survived longer while awaiting a heart transplant when they received therapy with Berlin Heart's Excor pediatric ventricular assist device than when treated with the current standard of care, according to a new study.
The Excor PAD device was not without risks, but survival rates for children on the device were "significantly higher" than those in the control group, according to the study's authors.
The study included 48 patients aged 16 and younger, split into 2 groups according to body size. Each group received the Excor implant while awaiting a donor heart, and results were compared with historical data from children who had been placed on heart-lung support machines, known as extracorporeal membrane oxygenation .